
NSDL IPO: Depository firm raises ₹1,200 crore from anchor investors ahead of public issue
NSDL allocated a total of 1,50,17,999 equity shares or 1.5 crore equity shares to the anchor investors at an allocation price of ₹ 800 per share, the company informed BSE in an exchange filing.
Of the total 1.5 crore equity shares allocated to the anchor investors 5,297,418 equity shares, nearly 35.27 per cent were allocated to 12 domestic mutual funds, who applied through a total of 22 schemes.
Life Insurance Corporation of India, Smallcap World Fund, SBI Banking & Financial Services Fund, ICICI Prudential ElSS Tax Saver Fund, HDFC Value Fund, Fidelity Funds- India Focus Fund, Ashoka Whiteoak ICAV are some of the key anchor investors who were allocated equity shares.
On Tuesday, July 29, the grey market premium (GMP) of NSDL IPO stood at ₹ 126 per share at 11:05 pm. With the upper price band at ₹ 800 per share, the shares of the company are expected to be listed at ₹ 926, with a premium of 15.75 per cent, according to data from Investorgain.
The NSDL initial public offering (IPO) opens tomorrow and will continue till August 1, 2025. The company has set the IPO price band at ₹ 760 to ₹ 800 per equity share. It plans to raise ₹ 4,011.60 crore through a fully offer-for-sale (OFS). The IPO is scheduled for listing on both NSE and BSE.
The proposed public issue plans to allocate up to 50 per cent of shares to Qualified Institutional Buyers (QIBs), at least 15 per cent to Non-Institutional Investors (NIIs), and a minimum of 35 per cent to retail investors. Moreover, up to 85,000 equity shares are reserved for eligible employees, who will benefit from a discount of ₹ 76 per share through the employee reservation segment.
Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
28 minutes ago
- Time of India
Ivy League colleges are not the priciest in the US: See which universities cost even more
In a finding that challenges long-held assumptions about the cost of elite education in the United States, a new study by GOBankingRates has revealed that the most expensive universities in the country are not part of the Ivy League. While institutions like Harvard, Yale, and Princeton continue to symbolise academic excellence, they have been outpriced by a number of prestigious—but non-Ivy—private universities when it comes to the total estimated cost of attendance. At the top of the list is the University of Southern California (USC), where the total cost for a four-year undergraduate program is projected to reach a staggering $394,900. That breaks down to nearly $100,000 per year, including tuition, room and board, fees, books, and other expenses. The most expensive colleges in the US According to the GOBankingRates analysis, the top five most expensive colleges in the U.S. all exceed a $385,000 four-year attendance estimate. These figures reflect the 'sticker price' before financial aid and scholarships are factored in, and they represent the full cost a family would pay without assistance. Here's how the top five stack up: University of Southern California (USC) – $394,900 Duke University Vanderbilt University Washington University in St. Louis Brown University Surprisingly, only one Ivy League school—Brown University—makes the top five. The rest are private, highly selective institutions located across the U.S., known for strong academics, high tuition, and rising living costs. Ivy League institutions: Comparatively more affordable? Despite their elite reputation, Ivy League universities are not the costliest options. Only four Ivies made the top 10: Brown University – #5 Cornell University – #6 Dartmouth College – #8 Yale University – #10 The remaining Ivy League institutions, all ranked outside the top 10, include: University of Pennsylvania – #11 Columbia University – #14 Princeton University – #19 Harvard University – #23 Perhaps most surprising: Harvard, often considered synonymous with exclusivity and wealth, ranks near the bottom of the top 25 most expensive universities. This could be due to its enormous endowment, which enables the school to provide generous financial aid packages, often making it more affordable than its sticker price suggests. Why are non-Ivies more expensive? The reasons behind the rising costs at non-Ivy institutions are multifaceted: Geographic Location: Schools in cities like Los Angeles (USC), Nashville (Vanderbilt), or St. Louis (WashU) face higher costs of living, which drive up on-campus housing and services. Institutional Resources and Amenities: Many of these schools have invested heavily in campus upgrades, state-of-the-art facilities, student wellness programs, and global study opportunities—all of which add to operational costs. Lack of Massive Endowments: Unlike Ivies such as Harvard and Princeton, which have multibillion-dollar endowments that help subsidize tuition, non-Ivies may rely more heavily on tuition revenue to maintain competitiveness. Strong National Reputations: Institutions like Duke and USC have built powerful brands that attract top students globally—enabling them to charge premium prices. What this means for students The findings serve as a cautionary reminder for families evaluating college choices: prestige doesn't always equal unaffordability. Many Ivy League schools, despite their brand power, offer robust financial aid that makes them more affordable than they appear. Meanwhile, families eyeing top private colleges outside the Ivy League should pay careful attention to: Net price vs. sticker price Merit-based scholarships Work-study opportunities Graduation rates and return on investment (ROI) The bigger picture With college affordability now central to the national conversation, this report underscores the urgent need for transparent pricing and wider access to aid information. The sticker shock of a nearly $400,000 education—at any institution—can be paralysing for middle-class families, many of whom fall through the cracks of traditional aid systems. Students are encouraged to use net price calculators, compare aid offers, and consider long-term outcomes, such as earning potential, alumni networks, and debt burden. TOI Education is on WhatsApp now. Follow us here . Ready to navigate global policies? Secure your overseas future. Get expert guidance now!


NDTV
an hour ago
- NDTV
Estonia Is Offering A Digital Nomad Visa For Less Than Rs 13,000 To Live And Work There For A Year
From having a rich history to being digitally advanced, Estonia in Europe is one of the most popular countries among travellers. It is also one of the first countries in the world to offer a Digital Nomad Visa. This visa allows remote workers to live and work from within its borders. If you are a freelancer, remote employee, or entrepreneur, you can live and work in the country for up to a year. Who Is Eligible An applicant must meet the following criteria to qualify for Estonia's Digital Nomad Visa: You are a remote worker, an employee, or an entrepreneur with a business registered outside Estonia. You work as a freelancer with mostly international clients. Earn a gross income of at least €4,500 (Rs 4,57,371 approx.) per month during the six months preceding the application. ALSO READ: Love Castles And Remote Work? This Romania Visa Lets You Live There For A Year Documents Required A valid passport A completed and signed visa application form. Proof of employment or business activity (contracts, business registration, etc.) Bank statements from the past six months showing qualifying income A letter of intent outlining your reasons for moving to Estonia and how you meet the eligibility criteria Proof of health insurance covering at least €30,000 (Rs 30,49,740 approx.) for the duration of your stay Clean criminal background certificate Proof of accommodation in Estonia One passport-sized photo Who Can Apply The visa is open to non-EU/EEA nationals who wish to work remotely while residing in Estonia for up to 12 months. You can apply for a Digital Nomad Visa if you are already legally living in Estonia on another visa. You can also visit Estonia to allow spouses and minor children to apply under family visa provisions, though you may require more documentation. How To Apply Step 1: Fill out the Digital Nomad Visa application form online through the Estonian Ministry of Foreign Affairs website. Step 2: Submit the application in person at your nearest Estonian embassy or consulate. You will have to pay the visa fee of €120 (Rs 12,199 approx.) Step 3: Provide all documents required. The Embassy may conduct a short interview to confirm your eligibility and the purpose of your stay. Step 4: Wait for the visa to get processed, which usually takes 15-30 days but can take longer in some cases.


Economic Times
an hour ago
- Economic Times
Emcure Pharmaceuticals reports 41% surge in Q1 net profit driven by strong domestic and international growth
Emcure Pharmaceuticals reported a strong first quarter with a 41% increase in net profit, reaching Rs 215 crore, and a 16% rise in revenue to Rs 2,101 crore. Growth was fueled by robust domestic and international performance, particularly in the rest of the world and Canada. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Pune-based Emcure Pharmaceuticals on Thursday reported a 41% year-on-year increase in first quarter net profit at Rs 215 from operations rose 16% to Rs 2,101 crore, driven by robust performance in domestic and international businesses. The company's EBITDA margins for April-June stood at 19.2% with EBITDA up 20.1% YoY. International business grew 22%, while the rest of the world business grew 42%. The company's Canada business grew 16.4% led by new launches and market share gains. Europe saw early benefits of new launches and grew 12.8%.'We continue to augment our portfolio in all our focus markets through in-licensing and in-house development,' said Satish Mehta, CEO and managing director, Emcure Pharmaceuticals Its domestic business grew 9.4% led by strong performance in all out key therapies and aided by new initiatives in derma and the quarter, the company strengthened its domestic business through expansion of its strategic partnership with Sanofi. Going forward, Emcure will be marketing and distributing Sanofi's oral anti-diabetic portfolio in addition to the cardiovascular portfolio.'The expanded Sanofi partnership positions us well in the fast-growing metabolic segment. We also have a strong product pipeline for both our domestic and international markets, which will fuel future growth. We remain focused on improving efficiencies to drive sustained improvement in margins,' Mehta of Emcure Pharmaceuticals closed 1.58% lower at Rs 1,398.80 apiece on the BSE on Thursday. The company announced the earnings during market hours.